McCann FitzGerald LLP has advised Alkermes plc on the deal, Arthur Cox has assisted Avadel Pharmaceuticals plc . Alkermes plc has entered into an agreement to...
Alkermes to Acquire Avadel Pharmaceuticals in $2.1 Billion Deal
Avadel Pharmaceuticals’ $96 Million Exchange of Convertible Notes
Arthur Cox advised Avadel Pharmaceuticals plc (Nasdaq: AVDL). Avadel Pharmaceuticals is a biopharmaceutical company focused on transforming medicines to transform lives. The company’s approach includes applying...
Avadel Pharmaceuticals’ $125 Million Equity Offering
Arthur Cox advised Avadel Pharmaceuticals plc (Nasdaq: AVDL). Jefferies LLC is acting as the sole book-running manager for the offering. LifeSci Capital LLC is acting as...
Avadel Pharmaceuticals’ $75 Million Royalty Financing
Goodwin Procter advised Avadel Pharmaceutics on the deal. Avadel announced its royalty agreement with RTW Investments, LP and certain of its affiliates for up to $75 million....
Avadel’s $96 Million Exchange of Convertible Notes
Goodwin advised Avadel on the deal. Avadel extended the maturity of $96.2 million of its convertible notes to 2027. Under the terms of the convertible note exchange...
Avadel Pharmaceutics’ $125 Million follow-on Equity Offering
Goodwin Procter advised Avadel Pharmaceutics plc on the deal. Avadel Pharmaceuticals announced an underwritten public offering of 10,000,001 of its ordinary shares, nominal value $0.01 per...
Jazz Pharmaceuticals Inc. v. Avadel CNS Pharmaceuticals LLC
Sidley Austin and Quinn Emanuel represented Jazz Pharmaceuticals, while Latham & Watkins, Morrison Foerster and McCarter & English represented Avadel. The Federal Circuit concluded that Jazz...